Featured Publications

Found 5 results
Filters: Keyword is Male  [Clear All Filters]
2017
Silver RT, Barel AC, Lascu E, Ritchie EK, Roboz GJ, Christos PJ, Orazi A, Hassane DC, Tam W, Cross NCP.  2017.  The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis.. Cancer. 123(14):2680-2687.
Kvasnicka HMichael, Orazi A, Thiele J, Barosi G, Bueso-Ramos CE, Vannucchi AM, Hasserjian RP, Kiladjian J-J, Gianelli U, Silver R et al..  2017.  European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.. Am J Hematol. 92(10):1062-1067.
2016
Gergis U, Kuriakose E, Shore T, Mayer S, Mark T, Pearse R, Schuster M, Feldman E, Roboz G, Ritchie E et al..  2016.  Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.. Clin Lymphoma Myeloma Leuk. 16(5):297-303.
Padula WV, Larson RA, Dusetzina SB, Apperley JF, Hehlmann R, Baccarani M, Eigendorff E, Guilhot J, Guilhot F, Hehlmann R et al..  2016.  Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.. J Natl Cancer Inst. 108(7)
2008
Robins EB, Niazi M.  2008.  Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies.. Pediatr Blood Cancer. 50(4):859-61.